Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized trial of generic substitution of antiepileptic drugs
2012-001017-16Phase 4Active
- Sponsor
- IRCCS Mondino Foundation
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of carbamazepine, valproic acid, lamotrigine, topiramate, levetiracetam and 1 more in epilepsy, mental disorder and neurological diseases (2 arms), sponsored by IRCCS Mondino Foundation. Started Oct 2012; status: active.
02
Drugs
carbamazepinevalproic acidlamotriginetopiramatelevetiracetam
03
Conditions
epilepsymental disorderneurological diseases
Beyond the preview
Go deeper on 2012-001017-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001017-16.